Atossa Genetics Inc (NASDAQ:ATOS), a medical equipment company based in United States, led the NasdaqCM gainers with a relatively large price hike in the past couple of weeks. As a small cap stock, which tends to lack high analyst coverage, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Let’s examine Atossa Genetics’s valuation and outlook in more detail to determine if there’s still a bargain opportunity. See our latest analysis for Atossa Genetics
What is Atossa Genetics worth?Good news, investors! Atossa Genetics is still a bargain right now. My valuation model shows that the intrinsic value for the stock is $35.28, but it is currently trading at US$2.38 on the share market, meaning that there is still an opportunity to buy now. However, given that Atossa Genetics’s share is fairly volatile (i.e. its price movements are magnified relative to the rest of the market) this could mean the price can sink lower, giving us another chance to buy in the future. This is based on its high beta, which is a good indicator for share price volatility.
What kind of growth will Atossa Genetics generate?Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. With profit expected to grow by 20.06% over the next couple of years, the future seems bright for Atossa Genetics. It looks like higher cash flows is on the cards for the stock, which should feed into a higher share valuation.
What this means for you:
Are you a shareholder? Since ATOS is currently undervalued, it may be a great time to increase your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.
Are you a potential investor? If you’ve been keeping an eye on ATOS for a while, now might be the time to enter the stock. Its prosperous future outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy ATOS. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.
Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Atossa Genetics. You can find everything you need to know about Atossa Genetics in the latest infographic research report. If you are no longer interested in Atossa Genetics, you can use our free platform to see my list of over 50 other stocks with a high growth potential.